{"id":"placebo-cream-without-active-substance","safety":{"commonSideEffects":[{"rate":null,"effect":"Skin irritation or sensitization (vehicle-related)"},{"rate":null,"effect":"Local erythema or pruritus"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Placebo formulations are inert vehicles used as control comparators in clinical trials to establish the efficacy of active drugs above baseline and psychological expectation. In phase 3 trials, placebo creams help distinguish genuine pharmacological activity from subjective symptom improvement driven by patient expectation, therapeutic ritual, and natural disease course. Any observed benefit in placebo-treated groups reflects non-specific mechanisms including patient-reported outcomes bias and regression to the mean.","oneSentence":"A placebo cream contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:26:48.264Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Control comparator in phase 3 clinical trials (indication-dependent on active comparator)"}]},"trialDetails":[{"nctId":"NCT07454525","phase":"NA","title":"Examine Impact of Topical Application of Active Versus Placebo on the Skin Microbiome in Sensitive Skin.","status":"NOT_YET_RECRUITING","sponsor":"AB Biotics, SA","startDate":"2026-02","conditions":"Skin, Skin Microbiome, Skin Microbiota","enrollment":45},{"nctId":"NCT05211830","phase":"PHASE1, PHASE2","title":"A Study to Evaluate Topically Applied SXR1096 Cream in Patients With Netherton Syndrome","status":"COMPLETED","sponsor":"Sixera Pharma","startDate":"2021-12-07","conditions":"Netherton Syndrome","enrollment":9},{"nctId":"NCT06706050","phase":"PHASE1, PHASE2","title":"Clinical Therapeutic Potential of Novel Microbiome LP-51 on Xerosis Individual Based on Xerosis-microbiome Index","status":"COMPLETED","sponsor":"Ho-Yeon Song","startDate":"2023-05-08","conditions":"Xerosis","enrollment":43},{"nctId":"NCT05861310","phase":"PHASE1","title":"Effectivity and Safety of Metronidazole 1% Cream in Rosacea Therapy","status":"UNKNOWN","sponsor":"Dr.dr.Irma Bernadette, SpKK (K)","startDate":"2023-05","conditions":"Rosacea","enrollment":48},{"nctId":"NCT03846648","phase":"PHASE1","title":"CyPep-1 in Cutaneous Warts","status":"COMPLETED","sponsor":"Centre for Human Drug Research, Netherlands","startDate":"2019-03-11","conditions":"Cutaneous Warts","enrollment":56},{"nctId":"NCT01943006","phase":"PHASE3","title":"Efficacy and Tolerability of Hirudoid Cream in Prophylaxis and Treatment Infusion Phlebitis","status":"COMPLETED","sponsor":"Medinova AG","startDate":"2015-05","conditions":"Thrombophlebitis, Phlebitis","enrollment":144}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":5,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Placebo cream without active substance","genericName":"Placebo cream without active substance","companyName":"Medinova AG","companyId":"medinova-ag","modality":"Small molecule","firstApprovalDate":"","aiSummary":"A placebo cream contains no active pharmaceutical ingredient and produces therapeutic effects solely through the placebo effect. Used for Control comparator in phase 3 clinical trials (indication-dependent on active comparator).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}